On February 11, 2019, we issued a press release announcing our findings from a physician survey focused on prescription drug costs. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The information in Item 8.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
04/08 OptimizeRx Expands Investment in Hospitals and Health Systems with Latest Tec..
03/20 OptimizeRx Survey Shows Providers Want to Engage with Patients on Drug Costs ..
03/12 OPTIMIZERX : Management's Discussion and Analysis of Financial Condition and Res..
03/04 OptimizeRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019..